Juvenile arthritis is a common condition in children that causes joint inflammation and pain. It can be classified as acute, sub-acute, or chronic based on the duration of symptoms. The most common type is juvenile idiopathic arthritis, which refers to conditions characterized by chronic joint inflammation. Treatment involves medications like NSAIDs and DMARDs to reduce inflammation and pain, physical or occupational therapy to maintain mobility, and surgery in severe cases to correct joint deformities. Nursing care focuses on alleviating pain, increasing mobility through exercise, promoting independence in self-care, and ensuring patients understand their condition and treatment plan.
Rheumatoid arthritis is the most common systemic inflammatory disease characterized by symmetrical joint involvement.
Extraarticular involvement, including rheumatoid nodules, vasculitis, eye inflammation, neurologic dysfunction, cardiopulmonary disease, lymphadenopathy, and splenomegaly, can be manifestations of the disease.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
3. Introduction
Arthriris is a common complaint in children. It
said to be present if there is swelling or effusion
in a joint or if there are any two of the following
four features
- Limitation of rang of motion
- Pain
- Tenderness
- Increased heat
4. Contd…
• It can be secondary to an underlying illness or
may be primary disease condition in itself.
• Clinical assessment based on a good history
and physical examination would provide more
diagnostic clues than indiscriminate laboratory
tests
• A convenient way to classify arthritis is based
on the duration of illness at the time of
presentation
5. Classification of arthritis
Acute arthritis( usually < 2weeks)
Arthritis associated with acute rheumatic fever
Transient (toxic) synovitis
Arthritis associated with Kawasaki disease,
HSP
Septic arthritis (S. aureus, H. influenza, N.
meningitides)
6. Contd…
Sub-acute arthritis (2-6 weeks)
Associated with SLE,polyarthritis nodosa
Bone pains associated with leukemia or
neuroblastoma
Associated with Lyme disease, Sickle cell
Associated with hypogammaglobulinemia
8. Juvenile idiopathic arthritis
• The term Juvenile idiopathic arthritis(JIA) was
proposed by the Pediatric Standing Committee of
the international League of Association for
Rheumatology(ILAR)
• It refers to a group of condition characterized by
chronic inflammatory changes of the joint
• It is defined as arthritis of one or more joints with
onset below the age of 16 year and persisting for
at least 6 weeks. It has following subtype
9. Subtypes
• Systemic
• Oligoarthritis
- Persistent
- Extended
• Polyarthritis: RFnegative
• Polyarthritis: RF positive
• Psoriatic arthritis
• Enthesitis related arthritis
• Undifferentiated arthritis
- Fits no other category
- Fits more than one category
10. Incidence
• JIA is not a rare disease
• prevalence is increasing trend
• Common in underdeveloped country
• Can occur in 0.4-1.3 per 1000children of below
16 years
• Common cause of disability in children
• Cause of chronic morbidity and school
absenteeism
• Common in girl
11. Etiology
• The immune system is intimately involved in
the evolution of the disease
• Genetic predisposition
12. Pathophysiology
• Systemic inflammatory process originating in
the synovium or synovial fluid involving
connective tissue and characterized by
destruction and proliferation of synovial
membrane.
• Phagocytosis produces enzymes within the
joint, causing inflammation.
• Collagen is destroyed over time and pannus
formations occur, narrowing the joint space.
13. Contd..
• May result in joint destruction, ankylosis and
deformity with loss of articulation and joint
motion.
• Inflammatory process can also affect the spine,
blood vessels, the pleural membrane of the lungs
or the pericardial sac.
• Condition may be short lived and limited or
progressive and severe.
• Spontaneous remissions and unpredictable
exacerbations can occur
14. Clinical features
• Systemic onset JIA
About 5-15% of patient with JIE may have acute onset of
disease with systemic prominent features
Features usually starts with – intermittent fever with
characteristics twice daily peak(quotidian fever), fever in
evening , maculopapular rash prominent in rash (difficult
to identify in dark skinned people),marked
irritability(decrease with fever), hepatosplenomegaly,
lymphadenopathy, moderate neutrophil leukocytosis,
increased ESR with thrombocytosis and RF is negative
15. Contd…
• Oligoarthritis
Most frequent type of JIA, about 60-70% of
patient, four or fewer large joint are affected
during the first 6 month of the disease.
Involvement usually asymmetrical . Joint
swelling rather than joint pain. Two subtype are
described :Persistent (if joint involvement 4 or
less) and extended (if joint involvement is more
than 4)
16. Contd…
It is more common in girl, age of 3-5 years,
small joints of hand and feet are not involved
• Polyarthritis- in 25-30%,common in girl, joint
pain, swelling is more common, fever and
malaise can be significant. Usually two
subtype: RF negative- occur at any age of
childhood. The knee wrist and hip joint are
mostly affected, small joint tent to less
involve, rheumatoid nodules are not seen
17. Contd…
RF positive: onset of age is late childhood and
early adolescence. The arthritis is symmetrical,
deforming usually typical in small joint specially
metatarsophalangeal and proximal
interphalangeal. Cervical spine could also
affected. Rheumatoid nodules also present.
18. Contd…
• Psoriatic arthritis
Present when there is arthritis with association of
psoriasis or any 2 of following criteria/features-
dactylitis, nail pitting and psoriasis in 1st degree
relatives. Involvement of both large and small
joint simultaneously. Or involvement of the
distal interphalangeal joint are important clinical
clue for diagnosis .
19. Contd…
• Enthesitis arthritis- the condition is more
common in boys, older than 8 years, large
joint of lower extremities is usually affected
later ankylosing spondylitis may develop in
adulthood, self limiting acute symptomatic
iritis may occur.
20. Characteristic Pattern of Joint
Involvement
• Begins with small joints in hands, wrists, and feet.
• Progressively involves knees, shoulders, hips,
elbows, ankles, cervical spine, and
temporomandibular joints.
• Symptoms are usually acute in onset, bilateral,
and symmetric.
• Joints may be hot, swollen, and painful; joint
stiffness often occurs in the morning.
• Deformities of the hands and feet can result from
misalignment and immobilization.
21. Laboratory investigation
• Should recognize the differing pattern of joint involvement
in various type of JIA.
• Synovial fluid aspiration for microscopy and culture is
indicated in children with monoarthritis because septic
arthritis need to included
• Complete blood count may required
• Bone marrow aspiration may be needed if use of
glucocorticoids is being contemplated for treatment of JIA.
• CRP
• RA
• RF
• LFT
22. • Antinuclear antibody (ANA) titer: Screening test for rheumatic
disorders, elevated in 25%–30% of RA patients. Follow-up tests
are needed for the specific rheumatic disorders, e.g., anti-RNP is
used for differential diagnosis of systemic rheumatic disease.
• Rheumatoid factor (RF): Positive in more than 80% of cases
(Rose-Waaler test).
• Latex fixation: Positive in 75% of typical cases.
• Agglutination reactions: Positive in more than 50% of typical
cases.
• Serum complement: C3 and C4 increased in acute onset
(inflammatory response). Immune disorder/exhaustion results in
depressed total complement levels.
• Erythrocyte sedimentation rate (ESR): Usually greatly increased
(80–100 mm/hr). May return to normal as symptoms improve.
• CBC: Usually reveals moderate anemia. WBC is elevated when
inflammatory processes are present.
23. • Immunoglobulin (Ig) (IgM and IgG): Elevation strongly
suggests autoimmune process as cause for RA.
• X-rays of involved joints: Reveals soft-tissue swelling, erosion of
joints, and osteoporosis of adjacent bone (early changes)
progressing to bone-cyst formation, narrowing of joint space, and
subluxation. Concurrent osteoarthritic changes may be noted.
• Radionuclide scans: Identify inflamed synovium.
• Direct arthroscopy: Visualization of area reveals bone
irregularities/degeneration of joint.
• Synovial/fluid aspirate: May reveal volume greater than normal;
opaque, cloudy, yellow appearance (inflammatory
response, bleeding, degenerative waste products); elevated levels
of WBCs and leukocytes; decreased viscosity and complement
(C3 and C4).
• Synovial membrane biopsy: Reveals inflammatory changes and
development of pannus (inflamed synovial granulation tissue).
24. Treatment
Multidisciplinary management is needed
• Physiotherapy and occupational therapy is
needed to prevent deformities
• physical therapy helps to reduce pain
,maintenance of posture and joint mobility,
improve muscle strength and prevents fixed
flexion deformities.
• Ophthalmologist consultation to prevent
Uveitis
25. Medical therapy
• NSAID are the mainstay of symptomatic
management , NSAID inhibit both isoforms of
the enzyme cyclo-oxygenase.
• Naproxen and Ibuprofen are used in children
• Indomethacin is believed to use in Enthesitis
arthritis
• Rey syndrome could develop in children
receiving NSAID, if there is recurrent viral
infection
26. Contd…
• Children with NSAID should watch for gastric
adverse effects.
• Dose(4-6wk) – ibuprofen 35-45mg/kg/day,
maximum 700mg/day QID
• Indomethacin- 1-2mg/kg/day, max-150mg/day
TDS
• Diclofenac- 2-3mg/kg/day, max- 150mg/day QID
• Piroxicam- .3-.6mg/kg/day, max- 20mg/day OD
(analgesic dose is usually half the anti-
inflammatory dose)
27. Contd…
• Disease modifying anti-rheumatic
drugs(DMARDs) need to started in almost all
children with polyarthritis. Weekly
methotrexate 15-25mg/m2/week given
subcutaneously or orally for management of
severe illness.
• Methotrexate is better in children than older,
and have fewer adverse effects
28. Contd…
• Hydroxychloroquine is useful with
methotrexate
• Intra- articular glucocorticoids are preferred
therapy for children with oligoarthritis and
who does not respond with initial NSAID
• Local steroid instillation may required for
patient with iridocyclitis
• Systemic glucocorticoid (prednisolone) for
severe arthritis
30. Course
• Oligoarthritis usually has good prognosis but localised
deformities can develop due to asymmetric growth of limb
• Children with RF positive polyarthritis have a disease
pattern similar to adult show erosive and deforming arthritis
• Treatment regime is always not satisfactory. Approximately
50% patient may undergo remission with minor residual
joint involvement.
• Untreated or partially treated JIA may develop flexion
contractures of hips, knee and elbows resulting permanent
disability.
• Neck stiffness is an especially debilitating problem and can
result in torticollis. Temporomandibular joint involvement
result in restricted opening and may require surgical
intervention.
31. Complication
• Anemia- is chronic ongoing inflammation ,is
almost always present in children with
pesistent active arthritis and serial hemoglobin
levels mirror disease activity rather closely.
Blood loss induced by NSAID can also
contributory factor for anemia.
• Chronic anterior Uveitis- may be clinically
silent and potentially blinding.
32. Contd…
• Macrophage activation syndrome with life
threatening condition with icterus, bleeding
tendency, leukopenia, thrombocytopenia, elevated
triglycerides etc.( so prompt intravenous
methylprednisolone administration is needed)
• Growth disturbances
• Secondary amyloidosis is rare complication
present with proteinuria and hypoalbuminemia
and so often irreversible.
33. Nursing management
Assessment
ACTIVITY/REST
• May report: Joint pain and tenderness worsened by movement
and stress placed on joint; morning stiffness (duration often l hr or
more), usually occurs symmetrically
• Functional limitations affecting ADLs, desired lifestyle, leisure time,
and occupation
• Fatigue; sleep disturbances
• May exhibit: Malaise
• Impaired ROM of joints; particularly hand (fingers and wrist), hips,
knees, ankles, elbows, and shoulders
• Muscle atrophy; joint and muscle contractures/deformities
• Decreased muscle strength, altered gait/posture
34. CARDIOVASCULAR
• May report: Intermittent pallor, cyanosis, then redness of
fingers/toes before color returns to normal (Raynaud’s phenomenon)
• EGO INTEGRITY
• May report: Acute/chronic stress factors (e.g., financial,
employment, disability, relationship factors)
• Hopelessness and powerlessness (incapacitating situation)
• Threat to self-concept, body image, personal identity (e.g.,
dependence on others)
FOOD/FLUID
• May report: Inability to obtain/consume adequate food/fluids
(temporomandibular joint [TMJ] involvement)
• Anorexia, nausea
• May exhibit: Weight loss
• Dryness of oral mucous membranes, decreased oral secretions;
dental caries (Sjögren’s syndrome)
35. HYGIENE
• May report: Varying difficulty performing self-care
activities; dependence on others
• NEUROSENSORY
• May report: Numbness/tingling of hands and feet, loss
of sensation in fingers
• May exhibit: Symmetrical joint swelling
PAIN/DISCOMFORT
• May report: Acute episodes of pain (may/may not be
accompanied by soft-tissue swelling in joints)
• Chronic aching pain and stiffness (mornings are most
difficult)
• May exhibit: Red, swollen, hot joints (during acute
exacerbations)
36. SAFETY
• May report: Difficulty managing homemaker/maintenance
tasks
• Persistent low-grade fever
• Dryness of eyes and mucous membranes
• May exhibit: Pale, shiny, taut skin; subcutaneous rounded,
non-tender nodules; lesions, leg ulcers
• Skin/periarticular local warmth, erythema
• Decreased muscle strength, altered gait, reduced ROM
• Sexuality
• May report: Difficulty engaging in sexual activity as
desired/abstinence
SOCIAL INTERACTION
• May report: Impaired interactions with family/others;
change in roles; isolation
37. Nursing Priorities
• Alleviate pain.
• Increase mobility.
• Promote positive self-concept.
• Support independence.
• Provide information about disease
process/prognosis and treatment needs.
38. Nursing diagnosis
• Impaired Physical Mobility related to pain and
restricted joint movement.
• Acute pain related to swollen, inflamed joints and
restricted movement.
• Fatigue related to chronic inflammatory process.
• Risk for Ineffective Therapeutic Regimen
Management related to insufficient knowledge of
condition, pharmacologic therapy, exercise
program, myths and community resources.
39. Relieving Pain and Discomfort
• Provide a variety of comfort measures (eg, application of heat or
cold; massage, position changes, rest; foam mattress, supportive
pillow, splints; relaxation techniques, diversional activities).
• Administer anti-inflammatory, analgesic, and slow-
acting antirheumatic medications as prescribed.
• Individualize medication schedule to meet patient’s need for pain
management.
• Encourage verbalization of feelings about pain and chronicity of
disease.
• Teach pathophysiology of pain and rheumatic disease, and assist
patient to recognize that pain often leads to unproven treatment
methods.
• Assist in identification of pain that leads to use of
unproven methods of treatment.
• Assess for subjective changes in pain.
40. Reducing Fatigue
• Provide instruction about fatigue: Describe relationship
of disease activity to fatigue; describe comfort measures
while providing them; develop and encourage a sleep
routine (warm bath and relaxation techniques that promote
sleep); explain importance of rest for relieving systematic,
articular,
• and emotional stress.
• Explain how to use energy conservation techniques
(pacing, delegating, setting priorities).
• Identify physical and emotional factors that can cause fatigue.
• Facilitate development of appropriate activity/rest schedule.
• Encourage adherence to the treatment program.
• Refer to and encourage a conditioning program.
• Encourage adequate nutrition, including source of iron from food
and supplements.
41. Increasing Mobility
• Encourage verbalization regarding limitations in
mobility.
• Assess need for occupational or physical therapy
consultation: Emphasize range of motion of affected
joints; promote use of assistive ambulatory devices;
explain use of safe footwear; use individual appropriate
positioning/posture.
• Assist to identify environmental barriers.
• Encourage independence in mobility and assist as
needed: Allow ample time for activity; provide rest
period after activity; reinforce principles of joint
protection and work simplification.
• Initiate referral to community health agency.
42. Facilitating Self Care
• Assist patient to identify self care deficits and factors that
• interfere with ability to perform self-care activities.
• Develop a plan based on the patient’s perceptions and
priorities on how to establish and achieve goals to meet self
care needs, incorporating joint protection, energy
conservation, and work simplification concepts: Provide
appropriate assistive devices; reinforce correct and safe use
of assistive devices; allow patient to control timing of self-
care activities; explore with the patient different ways to
perform difficult tasks or ways to enlist the help of someone
else.
• Consult with community health care agencies when
individuals have attained a maximum level of self care yet
still have some deficits, especially regarding safety.
43. Improving Body Image and Coping Skills
• Help patient identify elements of control over
disease symptoms and treatment.
• Encourage patient’s verbalization of feelings,
perceptions, and fears.
• Identify areas of life affected by disease.
Answer questions and dispel possible myths.
• Develop plan for managing symptoms and
enlisting support of family and friends to
promote daily function.
44. • Monitoring and Managing Potential Complications
• Help patient recognize and deal with side effects from
medications.
• Monitor for medication side effects, including GI
tract bleeding or irritation, bone marrow suppression,
kidney or liver toxicity, increased incidence of
infection, mouth sores, rashes, and changes in vision.
Other signs and symptoms include bruising, breathing
problems, dizziness, jaundice, dark urine, black or
bloody stools, diarrhea, nausea and vomiting, and
headaches.
• Monitor closely for systemic and local infections,
which often can be masked by high doses of
corticosteroids
45. Continuing Care
• Refer for home care as warranted (eg, frail patient
with significantly limited function).
• Assess the home environment and its adequacy
for patient safety and management of the disorder.
• Identify any barriers to compliance, and make
appropriate referrals.
• For patients at risk for impaired skin integrity,
monitor skin status and also instruct, provide, or
supervise the patient and family in preventive
skin care measures.
• Assess patient’s need for assistance in the home,
and supervise home health aides.
46. Contd..
• Make referrals to physical and occupational
therapists as problems are identified and
limitations increase.
• Alert patient and family to support services such
as Meals on Wheels and local Arthritis
Foundation chapters.
• Assess the patient’s physical and psychological
status, adequacy of symptom management, and
adherence to the management plan.
• Emphasize the importance of follow up
appointments to the patient and family.